Regional Outlook of the CIDP Market: North America, Europe, Asia-Pacific & Rest of World
The Chronic Inflammatory Demyelinating Polyneuropathy Market is experiencing steady growth due to the rising incidence of autoimmune neuropathies, increasing awareness of CIDP diagnosis, and expanding access to immunotherapies. Growing use of advanced biologics, IVIg therapies, and corticosteroids is significantly driving treatment adoption. Furthermore, improvements in neuromuscular...
0 Σχόλια 0 Μοιράστηκε 333 Views 0 Προεπισκόπηση
Προωθημένο